本页面由Tiger Trade Technology Pte. Ltd.提供服务

Caris Life Sciences, Inc.

18.95
+0.14000.74%
成交量:32.04万
成交额:606.03万
市值:53.47亿
市盈率:-5.89
高:19.20
开:18.80
低:18.61
收:18.81
52周最高:42.50
52周最低:17.15
股本:2.82亿
流通股本:9,191.75万
量比:0.79
换手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-3.2173
每股收益(LYR):-3.2200
净资产收益率:-45.37%
总资产收益率:3.84%
市净率:9.26
市盈率(LYR):-5.89

数据加载中...

2026/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/30

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/14

SEC问询函

Form CORRESP - Correspondence
2025/06/14

SEC问询函

Form CORRESP - Correspondence
2025/06/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/24

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/21

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/05/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership